InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,244.00
(
1.57%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.00%
)
Bitcoin
63,003.74
(
-1.15%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

MiamiGent

Send PM Follow Ignore
Followers 272
Posts 53130
Boards Moderated 3
Alias Born 08/16/2008

MiamiGent

Member Level

Re: None

Tuesday, 10/21/2014 6:01:34 AM

Tuesday, October 21, 2014 6:01:34 AM

Post# of 97237
NLNK NewLink in $1 bln deal with Roche to develop cancer drug
BY Reuters - 7:35 AM ET 10/20/2014

Oct 20 (Reuters) - NewLink Genetics Corp (NLNK) said it entered into a licensing agreement with Roche Holding AG (RHHVF) to develop NewLink's cancer immunotherapy, making the Ebola vaccine developer eligible to receive over $1 billion in milestone payments.

NewLink's shares jumped nearly 26 percent before the bell on Monday. http://stockcharts.com/h-sc/ui?s=NLNK

Immunotherapies are a class of drugs designed to help the body's own immune system fend off disease. (Reporting by Natalie Grover in Bangalore; Editing by Saumyadeb Chakrabarty)

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up